Cargando…
The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes
The prevention of cardiovascular morbidity and mortality has always been a primary concern in patients with type 2 diabetes. Modern trials of glucose-lowering therapies now assess major adverse cardiac events as an endpoint in addition to the effects on glycaemic control. Whilst the data on the effi...
Autores principales: | Wu, Linda, Gunton, Jenny E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928800/ https://www.ncbi.nlm.nih.gov/pubmed/31766545 http://dx.doi.org/10.3390/ijms20235853 |
Ejemplares similares
-
Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012) -
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
por: Kaul, Subuhi, et al.
Publicado: (2020) -
The Influence of Ethnicity on the Development of Type 2 Diabetes Mellitus in Women with Gestational Diabetes: A Prospective Study and Review of the Literature
por: Girgis, Christian M., et al.
Publicado: (2012) -
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
por: Mahgoub, Mohamed Omer, et al.
Publicado: (2023) -
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
por: Xu, James, et al.
Publicado: (2017)